Descriptive analysis of antibodies concentrations by Elecsys Anti-SARS-CoV-2 S and EliA SARS-CoV-2-Sp1 IgG in the 256 non-infected volunteers included in the study. by Antonio Fernández-Suárez (14053814)

eATP stimulation of RA decreased endothelial function. by Padmini Komalavilas (402160)

Image4_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

“…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”

Image2_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

“…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”

Image6_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

“…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”

Image1_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

“…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”

Image3_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

“…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”

Image7_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

“…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”

Table1_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.xlsx by Mohammad Arif Rahman (8267352)

“…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”

Carbon−Sulfur Bond Formation via Alkene Addition to an Oxidized Ruthenium Thiolate by Craig A. Grapperhaus (1666657)

“…During oxidation, the absorption bands of <b>1b</b> at 540, 797, and 1041 nm decrease in intensity. The resulting complex <b>[2a]</b><b>⁺</b> displays a single redox couple at +804 mV. …”

The thromboxane analogue, U-46619 decreased vessel diameter. by Simon C. Watkins (39900)

“…Changes in aortic flow velocity (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0044018#pone-0044018-g005" target="_blank">Figure 5</a>) in response to U-46619 in the 5 dpf embryos, were accompanied by decreases in vessel diameter (<b>E</b>, n = 5, <i>P</i><0.05). χ denotes statistical differences from baseline (time 0).…”

High glucose decreases antioxidant activities in endothelial cells. by Zhaoyun Zhang (118032)

“…Measurements were performed as described in Methods. High glucose causes a decrease in multiple antioxidant enzymes. A: G6PD activity. …”

Foldases and holdases each decrease the level of unfolded protein. by Adam MR de Graff (9767829)

Yta4 decreases the affinity of Dnm1 for GTP. by Jiajia He (795335)

Decreased Notch signaling in the retinoid-deficient spinal cord. by Marie Paschaki (179823)

Rapamycin acts in the brain to decrease body weight gain. by Mark Hebert (558822)

“…<p>A and B: RAP i.c.v. injection (Day 0, broken line) induces a transient decrease in body weight gain (A), which results in prolonged shift in body weight (B). …”

Inhibition of Hh signaling decreases hMSC proliferation. by Magali Plaisant (230886)

Overexpression of Mov10 decreases HIV-1 infectivity. by Vyacheslav Furtak (253807)

Retinoschisin secretion into the conditioned medium is decreased by addition of taxol. by Eiko Kitamura (349087)

“…Retinoschisin secretion into the medium decreases in a dose-dependent manner between 0.5 µM and 10 µM taxol. …”

Hedgehog signaling is decreased in <i>Foxa1</i>;<i>Foxa2</i> double knockouts. by Jennifer A. Maier (278698)

“…At E9.5, <i>Shh</i> mRNA is found in the brain, midline, and hindgut of control (A) <i>Foxa1</i> null (B) and <i>Foxa2</i> knockout embryos (C). …”